Developed in the setting of rhinorrhea so patient thought symptoms reflective of URI so treated symptomatically.
Patient received Lovenox 100mg in setting of arrhythmia and instructed to present to the ED.
Patient received ASA 325.
Started on heparin ggt without bolus (has already received Lovenox).
Regarding history of DVT, per patient reports two instances during which he was treated for coumadin in setting of DVT.
Has been off anticoagulation for several years.
Past Medical History: DM c/b neuropathy HTN OSA HL History of DVT status post left knee total replacement right fasciotomy of four compartments right knee replacement three times   Social History: Retired construction worker Lives in [**Location 5028**] with wife - [**Name (NI) 1139**]: 1yr hx 50yr ago - Alcohol: case of beer/week - Illicits: denies  Family History: No h/o of clot disorders or malignancies   Physical Exam: admission exam HEENT: Sclera anicteric, MMM, oropharynx clear, EOMI, PERRL Neck: supple, JVP not elevated, no LAD CV: tachycardic, irregularly irregular, normal S1 + S2, no murmurs, rubs, gallops Lungs: Clear to auscultation bilaterally, no wheezes, rales, ronchi Abdomen: soft, non-tender, non-distended, bowel sounds present, no organomegaly GU: no foley Ext: warm, well perfused, 2+ pulses, no clubbing, cyanosis or edema Neuro: CNII-XII intact, 5/5 strength upper/lower extremities, grossly normal sensation, 2+ reflexes bilaterally, gait deferred, finger-to-nose intact .
The procedure was aborted.
Medications and dosages are listed above (see Test Information section).
0.2 mg of IV glycopyrrolate was given as an antisialogogue prior to TEE probe insertion.
He was started on a heparin drip.
[**2177-3-28**] he was started on warfarin at an initial dose of 7.5mg daily which was briefly uptitrated to 10mg.
When therapeutic heparin gtt was discontinued and he was continued on warfarin 7.5 mg daily.
His coumadin will be managed as an outpatient by his PCP, [**Name10 (NameIs) 151**] [**Name Initial (NameIs) **] goal INR of [**3-14**].
Diltizem was also started and uptitrated.
Eventually he was transitioned to the long acting metoprolol succinate 200 mg daily and diltizem 360 mg daily.
He was discharged on this regimen and will follow up in [**Hospital **] clinic in 2 weeks.
# HTN: Lasix (which he does not take anyway) and lisinopril initially held in setting of acute clot.
He was continued on ASA 81mg.
He was  restarted on half his home dose of lisinopril at 10 mg daily.
CHRONIC INACTIVE ISSUES:  # Hyperlipidemia: on simvastatin 80 mg on admission, however this was decreased to 10 mg in the setting of starting diltiazem, given increased risk for rhabdomyolysis.
His metformin was held in the setting of dye load.
He was continued on his home dose of NPH insulin and managed with a humalog sliding scale.
His metformin was restarted on discharge.
# GERD: continued omeprazole  # Chronic LE pain: continued cymbalta and PRN tylenol  TRANSITION OF CARE ISSUES: # Anticoagulation: will need to have INR followed at his PCP's office for titration of his coumadin dosing.
# PE/DVT:  will likely need lifelong anticoagulation now, given recurrence of DVT.
Recommend follow up CT in 6 months # Patient remained FULL CODE on this admission  Medications on Admission: ATENOLOL -  (Prescribed by Other Provider) - 50 mg Tablet - 1 Tablet(s) by mouth daily DULOXETINE [CYMBALTA] - 60 mg Capsule, Delayed Release(E.C.)
- 1 Capsule(s) by mouth once daily FUROSEMIDE -  (Prescribed by Other Provider) - 40 mg Tablet - 1 Tablet(s) by mouth daily LIDOCAINE [LIDODERM] - 5 % (700 mg/patch) Adhesive Patch, Medicated - apply to affected area maximum 12 hours in a 24 hour period LISINOPRIL -  (Prescribed by Other Provider) - 20 mg Tablet - 1 Tablet(s) by mouth daily METFORMIN -  (Prescribed by Other Provider) - 500 mg Tablet - 2 Tablet(s) by mouth q am OMEPRAZOLE -  (Prescribed by Other Provider) - 20 mg Capsule, Delayed Release(E.C.)
- 1 Capsule(s) by mouth once a day SIMVASTATIN -  (Prescribed by Other Provider) - 80 mg Tablet - 1 Tablet(s) by mouth daily ASPIRIN -  (Prescribed by Other Provider) - 81 mg Tablet, Chewable - 1 Tablet(s) by mouth daily CALCIUM [CALCIO [**Doctor First Name 15**] [**Month (only) 16**]] -  (OTC) - 500 mg Tablet - 1 Tablet(s) by mouth twice a day DOCUSATE SODIUM - 100 mg Capsule - 1 Capsule(s) by mouth twice a day MULTIVITAMIN-MINERALS-LUTEIN [CENTRUM SILVER] -  (OTC) - Tablet - 1 Tablet(s) by mouth daily NPH INSULIN HUMAN RECOMB [HUMULIN N] -  (Prescribed by Other Provider) - 100 unit/mL Suspension - 50 units once a day  Discharge Medications: 1. duloxetine 30 mg Capsule, Delayed Release(E.C.)
2. omeprazole 20 mg Capsule, Delayed Release(E.C.)
3. warfarin 2.5 mg Tablet Sig: Three (3) Tablet PO Once Daily at 4 PM.
Disp:*90 Tablet(s)* Refills:*2* 4. lisinopril 10 mg Tablet Sig: One (1) Tablet PO once a day.
6. metformin 500 mg Tablet Sig: Two (2) Tablet PO once a day.
7. aspirin 81 mg Tablet, Delayed Release (E.C.)
9. docusate sodium 100 mg Capsule Sig: One (1) Capsule PO BID (2 times a day).
10. multivitamin-minerals-lutein     Tablet Sig: One (1) Tablet PO once a day.
NPH insulin human recomb 100 unit/mL Suspension Sig: Fifty (50) units Subcutaneous daily with dinner.
12. diltiazem HCl 180 mg Capsule, Extended Release Sig: One (1) Capsule, Extended Release PO DAILY (Daily).
Outpatient Lab Work Please have INR checked at your PCP's office on [**2177-4-10**] 14. simvastatin 10 mg Tablet Sig: One (1) Tablet PO once a day.
You were started on blood thinning medications to treat your clots.
This was treated with cardioversion (shocking your heart into a normal rhythm) and a medication to help slow your rate.
The following changes have been made to your medication regimen:  Please START taking - warfarin 7.5 mg daily - diltiazem 180 mg daily - lisinopril 10 mg daily (rather than 20 mg) - simvastatin 10 mg daily (rather than 80 mg, as this can interact with diltiazem)  Please STOP taking: - Atenolol .
Please take the rest of your medications as prescribed and follow up with your doctors [**First Name (Titles) 3**] [**Last Name (Titles) 1988**].
You will need to have your INR checked on Wednesday or Thursday at your primary doctor's office  Followup Instructions: Name: [**Last Name (LF) **],[**First Name3 (LF) **] P. Location: [**Hospital 46644**] MEDICAL ASSOCIATES Address: [**Location (un) 32946**], [**Location (un) **],[**Numeric Identifier 32948**] Phone: [**Telephone/Fax (1) 32949**] ***The office is working on an appt for you this week and will call you at home with the appt.
